Essentials of pharmaceutical packaging to prevent drug counterfeiting

RAKESH NALAM *

Andhra Pradesh, India.
 
Review
International Journal of Science and Research Archive, 2023, 09(02), 599–605.
Article DOI: 10.30574/ijsra.2023.9.2.0610
Publication history: 
Received on 21 June 2023; revised on 30 July 2023; accepted on 02 August 2023
 
Abstract: 
The purpose of this paper is to explain the process for pharmaceutical drug packaging with serialization regulatory requirements. Generally, pharmaceutical packaging deals with the labeling and packing of products including injectables, tablets, pills, and other forms of medication. It is essential to maintain the quality and safety of the product from the manufacturing site to the customer. When it comes to labeling, it provides identification for the product, such as dosage, strength, and name, and in packing, it secures the product from physical damage, contamination, and degradation. During the packing of products, there will be a set of standards to be maintained, such as GxP standards. The FDA has released some guidelines to be followed with the packaging of pharmaceutical products. Serialization is an additional mandatory requirement for the prescribed products to secure drugs from falsification and counterfeiting throughout the supply chain.
 
Keywords: 
Pharmaceutical packaging; Pharmaceutical Serialization; Contamination; GxP standards; FDA
 
Full text article in PDF: 
 
Copyright information: 

Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0